PRME
PRIME MEDICINE INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
PRIME MEDICINE INC (PRME) is held as common stock by 5 tracked hedge-fund managers, with a combined reported value of ~$42.37M; the largest are Cathie Wood, Ken Griffin, Steven Cohen. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 2 new, 2 added, 1 trimmed, 1 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Heating up
Common-stock holders51 also report options
Congress trades0
Price$2.88vs quarter-end-22.09%
Sectors0
This quarter's moves
Top holderNew2
Added2
Trimmed / sold2
Cathie WoodCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $591.1K— of portfolio160,2002026 Q2
Value $511.8K— of portfolio138,7002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $591.1K | — | — |
| Ken GriffinPUT | $511.8K | — | — |
ARK ETF holdings
Cathie Wood · dailyARK total shares held · drag to inspect
2026-09-29holds 7,597,275
- ARKGweight in fund1.00%$21.84M
ARK publishes full ETF holdings daily (SEC Rule 6c-11). Line shows ARK's total shares held over time (not price); markers are buy/sell days. Derived from public CSVs — research only, not investment advice.
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.